Mkts

Abbott Laboratories

NYSE: ABT
$109.40-0.76 (-0.69%)
As of Nov 3, 4:00 PM ET

Key statistics

Day range
108.94110.61
52-week range
81.97132.03
Today
Open109.36
Previous close109.40
Volume7.22M
Valuation
Market cap190.39B
P/E ratio40.50×
EPS (TTM)2.70
Income & risk
Dividend / yield2.37 / 1.98%
Beta0.50
Avg volume9.83M
Discussion

ABT News

Stories mentioning ABT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue11,164,00011,459,00011,369,00011,142,00010,358,00010,974,00010,635,00010,377,000
Cost of Goods Sold4,890,0004,922,0005,075,0004,854,0004,468,0004,942,0004,698,0004,603,000
Gross Profit6,274,0006,537,0006,294,0006,288,0005,890,0006,032,0005,937,0005,774,000
Operating Expenses
Research & Development767,000735,000766,000725,000716,000749,000713,000698,000
Sales General & Admin3,740,0003,129,0003,051,0003,091,0003,061,0002,907,0002,895,0002,936,000
Total Operating Expenses
Operating Income (Loss)1,345,0002,251,0002,057,0002,052,0001,693,0001,911,0001,859,0001,669,000
Interest Income106,00078,00077,00071,00082,00091,00091,00082,000
Interest Expense
Other Expense159,000134,000150,000137,000127,000154,000121,000(10,000)
Pretax Income1,449,0002,358,0002,180,0002,150,0001,778,0002,030,0001,940,0001,607,000
Tax Provision372,000582,000536,000371,000453,000(7,199,000)294,000305,000
Net Income (Loss)1,077,0001,776,0001,644,0001,779,0001,325,0009,229,0001,646,0001,302,000
Earnings Per Share (Basic)0.621.020.941.020.765.300.940.74
Earnings Per Share (Diluted)0.611.020.941.010.765.280.940.74
Weighted Average Shares Outstanding (Basic)1,742,4801,741,0001,742,1421,743,4371,739,2061,740,0001,739,4661,743,040
Weighted Average Shares Outstanding (Diluted)1,747,0731,748,0001,749,3611,750,8351,747,2201,748,0001,747,5971,751,153

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ABT

Abbott Laboratories (NYSE: ABT) is a stock listed on the New York Stock Exchange under the ticker symbol ABT. It last traded at $109.40 (Nov 3, 2026, 4:00 PM ET), down 0.7% on the day. That gives Abbott Laboratories a market capitalisation of $190.4B and a price-to-earnings ratio of 40.5.

Over the past 52 weeks ABT has traded between $81.97 and $132.03.

Revenue for the quarter ended Mar 31, 2026 was $11.2B; net income $1.1B. Revenue was up 7.8% from $10.4B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$11.2B$1.1B9.6%
Dec 31, 2025$11.5B$1.8B15.5%
Sep 30, 2025$11.4B$1.6B14.5%
Jun 30, 2025$11.1B$1.8B16.0%

From Abbott Laboratories’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…